Your Mounjaro price guide · October 2026
Benefits of GLP-1 Beyond Weight Loss: What the Evidence Supports (October 2026)
The benefits of GLP-1 medicines beyond weight loss come mainly from better blood sugar control and a calmer appetite, because these medicines improve how the body responds to insulin, slow stomach emptying and help you feel fuller sooner.1 Mounjaro is licensed in the UK for weight management and type 2 diabetes. Wider claims about the heart or inflammation are research topics, not licensed promises. Current as of October 2026.
One pen. Four weekly doses.
New customers£40 off your first order with code FIRST40. Standard price £169.99.

From your first consultation to ongoing care.
- GPhC-registered UK pharmacy
- Prescriber assessment
- Temperature-controlled delivery
- Advice from our pharmacy team
Compare UK Mounjaro Prices
Prices checked 12 October 2026
| Provider | 2.5mg | 5mg | 7.5mg | 10mg | 12.5mg | 15mg | Notes |
|---|---|---|---|---|---|---|---|
| £129.99First orderReorders £144.99 | £178.99First orderReorders £193.99 | £239.99First orderReorders £254.99 | £250.99First orderReorders £265.99 | £279.99First orderReorders £294.99 | £289.99First orderReorders £304.99 | Consultation and next-day tracked delivery included | |
| Boots Online Doctor | £179.00 | £199.00 | £259.00 | £299.00 | £319.00 | £339.00 | Free click & collect; cold-chain home delivery chargeable |
| Asda Online Doctor | £148.97 | £188.97 | £248.97 | £278.97 | £287.47 | £298.97 | Refrigerated delivery from £4.50; free click & collect |
| MedExpress | £179.99 | £189.99 | £249.99 | £279.99 | £299.99 | £309.99 | Delivery £2.90 to £3.95; new-customer discount at checkout |
| Simple Online Pharmacy | £169.00 | £199.99 | £259.99 | £279.99 | £299.99 | £319.99 | Delivery £4.99 per order |
| Oxford Online Pharmacy | £143.96 | £188.96 | £248.96 | £278.96 | £288.96 | £309.95 | Free consultation; cold delivery £5.49 |
| Chemist4U | £148.00 | £188.00 | £248.00 | £278.00 | £288.00 | £298.00 | Consultation included; free temperature-controlled delivery |
| Chemist Click | £163.99 | £173.99 | £232.99 | £259.99 | £279.99 | £299.49 | Cold-chain delivery charged; £20 off with code |
| Click Pharmacy | £169.99 | £189.99 | £239.99 | £269.99 | £289.99 | £299.99 | Free assessment; delivery £3.50 to £7.95 |
| Medino | £147.99 | £169.99 | £249.99 | £269.99 | £299.99 | £319.99 | Consultation and delivery included |
Prices collected weekly from each provider's published price list.
A quick overview
What to know
before you start.
-
GLP-1 medicines act on appetite, stomach emptying and the body's response to insulin, so effects go beyond the number on the scales.
-
Mounjaro is licensed in the UK for weight management and for type 2 diabetes, which is the clearest non-weight benefit.
-
Claims about heart protection, inflammation or sleep are active research areas, not promises for any individual.
-
Treatment works alongside a reduced-calorie diet and increased physical activity, and individual results vary.
-
A GPhC-registered prescriber decides whether treatment suits you; ask them how it fits your wider health.
In this guide
01 · The core answer
What are the benefits of GLP-1 other than weight loss?
The clearest benefits of GLP-1 other than weight loss are metabolic: improved insulin response, slower stomach emptying and better appetite regulation.1 Mounjaro is licensed in the UK for type 2 diabetes as well as weight management, so blood sugar management is a recognised use, not a side benefit.1
They depend on which medicine you take, why you take it, your existing conditions and how you respond. A prescriber can tell you which of these is realistic for you.
| Area | What is known for Mounjaro | What it does not mean |
|---|---|---|
| Weight management | Licensed in adults; SURMOUNT-1 trial averages, individual results vary | Any individual outcome |
| Type 2 diabetes | Licensed for type 2 diabetes in the UK | That it replaces your diabetes care team's advice |
| Insulin response | Helps the body respond better to insulin | A specific change in your own readings |
| Appetite and fullness | Most people feel fuller sooner and less hungry between meals | That hunger disappears entirely |
| Heart, inflammation, sleep, other organs | Active research areas in the wider GLP-1 field | Any promise of protection for you |
02 · Your decision
Is this relevant to me, and what should I do next?
It is relevant if you are weighing treatment and want to understand what it may do for your health overall, not just your weight. The sensible next step is a conversation with a prescriber who can look at your history, medicines and goals together.
If you are considering private treatment, our Mounjaro pen and consultation page shows live availability. The consultation is free and every order is reviewed by a GPhC-registered prescriber. For the wider picture of our service, visit our weight loss clinic.
03 · How GLP-1 works
How GLP-1 medicines work in the body
GLP-1 is a natural gut hormone, and medicines that mimic it act on several systems at once, which is why their effects reach beyond appetite. Tirzepatide, the medicine in Mounjaro, is the first treatment of its kind to activate two natural gut-hormone receptors at once: GIP and GLP-1.1
Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin.1 Each of those three actions is a benefit in its own right. Better appetite regulation changes how you relate to food. Slower stomach emptying changes how long a meal keeps you satisfied. A better insulin response matters for anyone whose blood sugar control is a concern.
In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet.1 Notice the wording: the medicine supports the diet, it does not replace it.
This dual action is what distinguishes Mounjaro from single-action GLP-1 medicines such as semaglutide, which is sold as Wegovy and Ozempic.1 If you want to compare the brands, our overview of GLP-1 benefits is a good companion read, and the Wegovy pen page covers the alternative.
04 · Blood sugar and diabetes
Blood sugar and type 2 diabetes
Blood sugar management is the best-established benefit beyond weight loss, because Mounjaro is licensed in the UK for type 2 diabetes as well as for weight management.1 Tirzepatide improves the way the body responds to insulin.1
If you have diabetes, your diabetes team should stay involved. Starting or stopping any medicine that affects blood sugar is a conversation to have with them, not something to arrange alone.
One practical point: if you already take insulin or sulfonylureas, your doses may need adjusting because of the risk of low blood sugar. Tell the prescriber about every medicine you take during your consultation.
Our guide to GLP-1 drug benefits beyond obesity explores this wider territory in more depth.
05 · Appetite and eating habits
Appetite, fullness and your relationship with food
The most noticeable non-scale effect for many people is a quieter appetite: feeling fuller sooner and less hungry between meals.1 That is a real change in daily life, separate from any number on the scales.
It gives you room to build better habits. When constant snacking urges ease, it is easier to plan meals, notice portion size and choose foods deliberately. The medicine is a support, and the habits you build are what you carry forward. That is why Mounjaro is used alongside a reduced-calorie diet and increased physical activity.
It is also honest to say that this effect is not identical for everyone. Some people notice a strong change quickly, others a gentler one. Neither pattern tells you in advance how treatment will go, and your prescriber reviews progress as part of ongoing monthly reviews.
Eating less does mean paying attention to nutrition. Smaller appetites can make it easy to under-eat protein, fibre and fluids. Ask your prescriber what a balanced plate looks like for you.
06 · Weight results in context
The weight results, in context
Weight change is still the headline result, and it underpins several wider health goals. In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.2
These are trial averages. Individual results vary, and treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.2 Trial averages do not predict your own result.
If weight is your main interest, the page on benefits of Mounjaro besides weight loss and our weight-focused guide cover the specifics.
07 · Heart, inflammation and sleep
Heart health, inflammation and sleep: what is research, not promise
What you can do is ask your prescriber how your own heart health, sleep and blood pressure are being considered, and keep your regular GP checks going.
The same caution applies to safety. The EMA's safety committee reviewed the evidence and concluded in 2024 that it does not support a causal link between GLP-1 medicines and suicidal thoughts, and the MHRA keeps this under continuous review.17 If you notice a new symptom, tell your prescriber and report it through the Yellow Card scheme.19
If you have thoughts of harming yourself or ending your life, get help straight away. Call 999 or go to A&E if you are in immediate danger. In England you can call NHS 111 and choose the mental health option, any time. You can also call Samaritans free on 116 123, day or night. Tell your prescriber about any change in your mood while taking Mounjaro. Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing.
08 · NHS and private access
Getting treatment: NHS and private routes
Mounjaro is available on the NHS, but access is being phased in over several years.4 NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions).6 Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.
If you go private, choose a pharmacy that appears on the GPhC register. Ours is GPhC 9012878, and you can check it on the public register.12
Beware of anyone offering to supply without a consultation or prescription. Counterfeit pens are a real risk, and the MHRA publishes alerts.7
09 · Stopping and long term
What happens when you stop
Tirzepatide has a half-life of about five days, so after a final dose it takes roughly four to five weeks to clear the system. There is no way to speed this up, and nothing needs doing while it clears.1
This matters for the wider benefits. Appetite effects are linked to the medicine acting in your body, so plan with your prescriber before you stop. In SURMOUNT-4, people who stopped tirzepatide after 36 weeks regained on average 14% of body weight over the following year, while those who continued treatment lost a further 5.5% on average. Stopping should always be planned with your prescriber, with diet and activity habits ready to carry the load.
Our aftercare includes ongoing monthly reviews, dose titration and follow-up assessments, plus side-effect support. Repeat orders re-check suitability, and there is no auto-shipping. You can also track your journey with the free GLPTrackr app. For more on other brands and options, see benefits of GLP-1 medications and beyond weight loss jabs.
How ordering works
How ordering works at EverydayMeds
Three steps, with our pharmacy team alongside you.
Step 1: Online consultation — 5–10 minutes
Complete a confidential health questionnaire covering BMI, medical history and current medication. No payment is taken until you're approved.
Step 2: Prescriber review — usually same day
A UK registered prescriber checks your suitability against the licensed criteria (BMI ≥30, or ≥27 with a weight-related condition) and contraindications, and confirms your starting dose.
Step 3: Next-day tracked delivery
Dispensed by our GPhC-registered pharmacy in temperature-controlled packaging with needles and a sharps bin included. Orders approved by 3pm for next-day tracked delivery.
Prescription and dispatch follow clinical approval. Confirm current delivery options when ordering.
Afterwards you're not on your own: dose-change reviews are built in before each step up, our pharmacist team is available for side-effect questions, and repeat orders re-check suitability rather than auto-shipping.
Your questions, answered
Mounjaro price UK — frequently asked questions
Answers to common questions about Mounjaro prices, NHS access and ongoing treatment.
Ask our pharmacy teamWhat are the benefits of GLP-1 other than weight loss?
Can you take GLP-1 and not lose weight?
Does GLP-1 help with belly fat?
Where do you lose weight first on GLP-1?
Does GLP-1 cause the stomach to shrink?
Which GLP-1 has the least side effects?
Why is everyone on GLP-1?

Clinically reviewed by
Mahommed Zunaid Ayub Patel
Superintendent Pharmacist
Accountable for the safe running of our registered pharmacy — from dispensing checks to delivery.
GPhC registration no. 2217101 · check the GPhC register
- Reviewed
- Last updated
- Next review
How we source our information
How we source our information: every clinical statement on this page is drawn from the sources below. Our prices are shown live from our pharmacy's product listings, and competitor prices show the date they were collected.
Sources — 10 references
- Mounjaro KwikPen — Summary of Product Characteristics (SmPC), electronic medicines compendium (EMC), 2026
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med 2022;387:205–216
- Frías JP, et al. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes (SURPASS-2). N Engl J Med 2021;385:503–515
- NICE TA1026 — Tirzepatide for managing overweight and obesity, including the practical prescribing guide
- NHS England — Weight management injections: rollout guidance
- MHRA — guidance on contraception with GLP-1/GIP medicines; counterfeit medicine alerts and Yellow Card scheme
- NICE TA924 — Tirzepatide for treating type 2 diabetes
- GPhC — public register of pharmacies and pharmacy professionals
- Mounjaro KwikPen — Patient Information Leaflet (emc)
- MHRA Yellow Card scheme — report a side effect
EverydayMeds is operated by OVIO Ltd · GPhC-registered pharmacy 9012878 · Registered premises, Leicester · Superintendent Pharmacist: Mahommed Zunaid Ayub Patel


